NCT05719545 A Cohort of Patients Undergoing Percutaneous Coronary Intervention
| NCT ID | NCT05719545 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Su Guohai |
| Condition | Acute Coronary Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2021-12-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2021-12-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the risk factors involved in the occurrence and prognosis of the patients with acute coronary syndrome, patients undergoing percutaneous coronary intervention will be recruited and followed up for at least 2 years.
Eligibility Criteria
Inclusion Criteria: * Diagnosed as acute coronary syndrome and needed to undergo percutaneous coronary intervention. * \>18 years old. Exclusion Criteria: * With malignant tumors, acute infectious diseases and advanced liver diseases. * Won't sign an inform consent.
Contact & Investigator
Guohao Su, doctor
PRINCIPAL INVESTIGATOR
Jinan Central Hospital
Frequently Asked Questions
Who can join the NCT05719545 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Acute Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05719545 currently recruiting?
Yes, NCT05719545 is actively recruiting participants. Contact the research team at huangrong9277@163.com for enrollment information.
Where is the NCT05719545 trial being conducted?
This trial is being conducted at Jinan, China.
Who is sponsoring the NCT05719545 clinical trial?
NCT05719545 is sponsored by Su Guohai. The principal investigator is Guohao Su, doctor at Jinan Central Hospital. The trial plans to enroll 10,000 participants.